LGI1 encephalitis in childhood
Authors:
E. Štěpánová 1,2,3; H. Medřická 1,2; I. Doležalová 4; P. Hanzlíková 5,6,7
Authors‘ workplace:
Oddělení dětské neurologie, FN Ostrava
1; Katedra neurověd, OU Ostrava
2; LF UP a FN Olomouc
3; I. neurologická klinika LF MU a FN u sv. Anny v Brně
4; Ústav radiodiagnostický, FN Ostrava
5; Ústav zobrazovacích metod, OU Ostrava
6; Radiologická klinika LF UP a FN Olomouc
7
Published in:
Cesk Slov Neurol N 2023; 86(3): 208-210
Category:
Letter to Editor
doi:
https://doi.org/10.48095/cccsnn2023208
Sources
1. Mayasi Y, Deepak T, Garg N. Leucine-rich glioma-inactivated protein 1 antibody encephalitis. Neurol Neuroimmunol Neuroinflamm 2014; 1(4): 51–54. doi: 10.1212/ NXI.0000000000000051.
2. Krýsl D, Elišák M. Autoimunitní encefalitidy. Cesk Slov Neurol N 2015; 78/ 111(1): 7–23. doi: 10.14735/ am csnn20151.
3. Doležalová I, Kuba R, Brázdil M et al. Neparaneoplastická limbická encefalitida s pozitivitou anti LGI 1 protilátek. Neurol Praxi 2012; 13(4): 221–224.
4. Krýsl D, Marusič P. Autoimunitní limbické encefalitidy. Neurol Praxi 2012; 13(3): 160–164.
5. Zborníková P, Krasulová E, Bušek P et al. Autoimunitní limbická encefalitida asociovaná s LGI1 protilátkami. Neurol Praxi 2012; 13(6): 343–346.
6. Abboud H, Probasco JC, Irani S et al. Autoimmun encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry 2021; 92(7): 757–768. doi: 10.1136/ jnnp-2020-325300.
Labels
Paediatric neurology Neurosurgery NeurologyArticle was published in
Czech and Slovak Neurology and Neurosurgery
2023 Issue 3
Most read in this issue
- Analysis of a patient group with head and facial injuries in scooter accidents treated at the Central Military Hospital in Prague from 2010 to 2022
- Verification of the psychometric properties of the Slovak version of the Dementia Rating Scale-2 in a healthy population and in patients with Parkinson‘s disease – a pilot study
- Benefits and pitfalls of carotid stents with dual-layer design – a systematic review
- Pituitary adenylate cyclase activating polypeptide (PACAP) and its role in migraine pathophysiology